~~<i id='1CFF28E45F'><strike id='1CFF28E45F'><tt id='1CFF28E45F'><pre id='1CFF28E45F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：knowledge 2025-10-01 14:15:58 - browse：83

LONDON — GSK said Tuesday it would purchase the asthma-focused drug developer Aiolos Bio for $1 billion upfront, the latest in a string of pharma acquisitions that are bolstering hopes for the industry’s year ahead.

The deal includes up to another $400 million in payments if certain milestones are met.

Aiolos was launched just last year, based in both San Francisco and London. The company, which announced a $245 million Series A round in October, has been readying a Phase 2 trial of its candidate AIO-001 in adult asthma.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Chemotherapy before breast cancer surgery might fuel metastasis

Wikipedia

knowledge

focus

knowledge

hotspot

Wikipedia

Roche'sboothatthe2023ESMOconference.AndrewJoseph/STATMADRID—ARochedrugloweredtheriskofrecurrenceorde

WSS

STAT Summit: How researchers deal with rejection

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Why a market frenzy over new weight loss drugs defies logic

AltruBio raises $225 million to develop ulcerative colitis drug

AI for drug discovery: Experts on separating hype from reality

Can gargling with Listerine treat gonorrhea of the mouth?

focus

comprehensive

Wikipedia

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

How a small hospital in rural Puerto Rico survived Hurricane Maria

Psychedelics group wrestles with new pharma identity

Black vets could get higher VA benefits if race not used in lung test

Walensky prepares to leave CDC — and Congress — behind

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Walensky prepares to leave CDC — and Congress — behind

Roche drug slashes death risk in early

In age of alternative facts, a scholarly course on calling out crap

How a small hospital in rural Puerto Rico survived Hurricane Maria

knowledge

Smaller biotechs seek to piggyback on weight loss drug boom

Primary care doctor shortage won't be solved by free med school tuition

UnitedHealth, Optum discontinue NaviHealth name

Can gargling with Listerine treat gonorrhea of the mouth?

Lawmakers grill UnitedHealth CEO on Change cyberattack

Is it ever OK for doctors to lie to their patients?

focus

knowledge

hotspot

Wikipedia